rs145786819
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_014324.6(AMACR):c.554T>C(p.Val185Ala) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,613,938 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014324.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AMACR | NM_014324.6 | c.554T>C | p.Val185Ala | missense_variant, splice_region_variant | 4/5 | ENST00000335606.11 | |
C1QTNF3-AMACR | NR_037951.1 | n.910T>C | splice_region_variant, non_coding_transcript_exon_variant | 8/9 | |||
AMACR | NM_001167595.2 | c.554T>C | p.Val185Ala | missense_variant, splice_region_variant | 4/6 | ||
AMACR | NM_203382.3 | c.393T>C | p.Gly131= | splice_region_variant, synonymous_variant | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AMACR | ENST00000335606.11 | c.554T>C | p.Val185Ala | missense_variant, splice_region_variant | 4/5 | 1 | NM_014324.6 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000841 AC: 128AN: 152184Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000947 AC: 238AN: 251326Hom.: 1 AF XY: 0.00105 AC XY: 142AN XY: 135836
GnomAD4 exome AF: 0.00114 AC: 1664AN: 1461636Hom.: 3 Cov.: 33 AF XY: 0.00118 AC XY: 858AN XY: 727150
GnomAD4 genome ? AF: 0.000827 AC: 126AN: 152302Hom.: 1 Cov.: 33 AF XY: 0.000658 AC XY: 49AN XY: 74466
ClinVar
Submissions by phenotype
not provided Uncertain:4Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 21, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jan 29, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Oct 14, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 30, 2021 | - - |
Alpha-methylacyl-CoA racemase deficiency Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Nov 01, 2022 | This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 185 of the AMACR protein (p.Val185Ala). This variant is present in population databases (rs145786819, gnomAD 0.2%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with clinical features of AMACR-related conditions (PMID: 20818383, 25133958). ClinVar contains an entry for this variant (Variation ID: 235439). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
AMACR-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 11, 2023 | The AMACR c.554T>C variant is predicted to result in the amino acid substitution p.Val185Ala. This variant was reported in an individual with complex I deficiency and an individual with ataxia (Table S2, Calvo et al. 2010. PubMed ID: 20818383; Table 2, Fogel et al. 2014. PubMed ID: 25133958). This variant is reported in 0.15% of alleles in individuals of South Asian descent in gnomAD, including a homozygous observation (http://gnomad.broadinstitute.org/variant/5-33998931-A-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at